Financial Performance - The company's total revenue for the fiscal year 2023 decreased by approximately 26.1%, from about HKD 131.6 million in fiscal year 2022 to approximately HKD 97.2 million[4]. - The revenue from the book products segment accounted for about 92.2% of total revenue in fiscal year 2023, with approximately HKD 89.7 million, a decrease of 28.3% compared to HKD 125.0 million in fiscal year 2022[6]. - The net loss for fiscal year 2023 decreased to approximately HKD 3.7 million, compared to a net loss of about HKD 16.5 million in fiscal year 2022[16]. - The company reported a net loss of approximately HKD 3,690,000 for the fiscal year 2023, compared to a loss of approximately HKD 16,500,000 in 2022, representing a significant improvement[49]. - Earnings per share for 2023 was HKD (0.36), a decrease from HKD (1.64) in 2022, indicating a reduction in losses per share[62]. - Total revenue for 2023 was HKD 97,241,000, down from HKD 131,647,000 in 2022, reflecting a decline of approximately 26%[62]. - The cost of sales decreased to HKD (75,690,000) in 2023 from HKD (123,978,000) in 2022, resulting in a gross profit of HKD 21,551,000, compared to HKD 7,669,000 in the previous year[62]. - The gross profit for fiscal year 2023 was approximately HKD 21.6 million, an increase of 181.0% from about HKD 7.7 million in fiscal year 2022[7]. - The gross profit margin increased from 5.8% in fiscal year 2022 to 22.2% in fiscal year 2023[8]. Assets and Liabilities - As of December 31, 2023, the company's total assets were HKD 150.329 million, with shareholders' equity at HKD 126.603 million[21]. - The company held cash and bank balances of approximately HKD 65.6 million as of December 31, 2023, an increase of about 15.0% from HKD 57.1 million on December 31, 2022[21]. - Non-current assets decreased to approximately HKD 35.7 million as of December 31, 2023, down from about HKD 43.3 million on December 31, 2022[23]. - Current assets increased to approximately HKD 114.6 million as of December 31, 2023, compared to HKD 107.0 million on December 31, 2022[23]. - The total lease liabilities of the group as of December 31, 2023, amounted to approximately HKD 6.6 million (as of December 31, 2022: approximately HKD 1.8 million)[25]. - The group's debt-to-equity ratio as of December 31, 2023, was approximately 5.2% (as of December 31, 2022: approximately 1.4%)[25]. - The group maintained a current ratio of approximately 5.8 as of December 31, 2023 (as of December 31, 2022: approximately 5.7)[25]. - The total equity of the group decreased to HKD 126,603,000 in 2023 from HKD 131,607,000 in 2022, a decline of 3.8%[78]. Operational Strategies - The company plans to improve marketing strategies, expand its quality customer base, and promote one-stop printing services to capture new business opportunities[17]. - The company plans to utilize approximately HKD 20.7 million for pharmaceutical-related projects by December 31, 2024, with HKD 13.7 million remaining unutilized as of the announcement date[45]. - The group has no plans for significant acquisitions, disposals, or investments as of the announcement date[36]. - The company did not recommend any final dividend for fiscal year 2023, consistent with fiscal year 2022[107]. Governance and Compliance - The audit committee has reviewed the external auditor's terms of engagement and the financial statements for the fiscal year 2023, ensuring compliance with applicable accounting standards[65]. - The company has implemented high standards of corporate governance and has adhered to the corporate governance code, with a commitment to regular reviews of its governance practices[53]. - The company has maintained a public float of at least 25% of its issued share capital as of the announcement date[58]. Other Financial Information - Total employee costs for the fiscal year 2023 were approximately HKD 34.7 million (fiscal year 2022: approximately HKD 42.4 million)[33]. - The group acquired properties, plants, and equipment for approximately HKD 0.5 million in fiscal year 2023 (fiscal year 2022: HKD 1.1 million)[29]. - The group did not enter into any hedging instruments to mitigate foreign exchange risks during the fiscal year 2023[28]. - The group reported bank interest income of HKD 792,000 in 2023, significantly up from HKD 41,000 in 2022[88]. - The group received government grants totaling HKD 101,000 in 2023, down from HKD 470,000 in 2022[88]. - The group reported a net loss from the sale of property, plant, and equipment of HKD 25,000 in 2023, compared to a gain of HKD 11,000 in 2022[95]. - The company had no non-current assets related to potential investments as of the end of fiscal year 2023, down from HKD 7 million in fiscal year 2022[100]. - Trade receivables at the end of fiscal year 2023 totaled HKD 29.2 million, down from HKD 41.4 million in fiscal year 2022[100]. - The total trade and other payables at the end of fiscal year 2023 amounted to HKD 16.6 million, an increase from HKD 15.6 million in fiscal year 2022[108]. - The average number of ordinary shares weighted for the basic loss per share calculation was 1,020,000 shares in fiscal year 2023, compared to 1,008,164 shares in fiscal year 2022[99]. - The company issued 20 million new shares in August 2022, raising approximately HKD 20.7 million after expenses[110].
竣球控股(01481) - 2023 - 年度业绩